The remuneration committee is comprised of Niels Mengel (chairman) and Peter Benson. The remuneration committee’s role is primarily to prepare matters regarding remuneration and other terms of employment for the CEO and other senior executives. The remuneration committee shall also monitor and evaluate ongoing and completed programs for variable remuneration to the Ascelia Pharma’s management and to monitor and evaluate the implementation of the guidelines for remuneration to senior executives which the Annual General Meeting has adopted.
Ascelia Pharma is a biotech company focused on orphan oncology treatments. We develop and commercialize novel drugs that address unmet medical needs and have a clear development and market pathway. […]
Ascelia’s employees are passionate and driven to develop products that will help people with rare cancer conditions live longer and healthier lives. Jeanette Nilsson Clinical operations manager “- As the […]